Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 48
Healthy volunteers: yes

Brief summary:
The objective of this study is to evaluate the effect of multiple doses of BI 207127 combined with faldaprevir on cardiac safety parameters in healthy subjects

Detailed description:

Arms:
arm 1: Tablets/capsules arm 2: Tablets arm 3: Tablets/capsules

Interventions: intervention 1: BI 207127 intervention 2: BI 207127 placebo intervention 3: Faldaprevir placebo intervention 4: Faldaprevir intervention 5: Moxifloxacin (Avalox®)
Intervention descriptions: intervention 1: Medium dose oral administration intervention 2: None intervention 3: None intervention 4: Medium dose oral administration intervention 5: None

Protocol document: